Lycera reaches marker in research collaboration with Merck Pharmaceutical Business revaluation The collaboration is focused on developing potential drug candidates to treat great autoimmune diseases such As rheumatoid arthritis, psoriasis , inflammatory bowel disease and multiple sclerosis. In Mar 2011, the companies entered into a research ... Lycera Achieves First marker in Merck Research cooperation MarketWatch (press release) another News To Note BioWorld Online all 12 tidings articles » Link To Article
No comments:
Post a Comment